Male Hypogonadism Therapy Market Insights, Global Outlook and Forecast 2022-2028
Male Hypogonadism Therapy Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Male Hypogonadism Therapy Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Male hypogonadism, also known as testosterone deficiency, is a failure of the testes to produce the male sex hormone testosterone, sperm, or both. It can be due to a testicular disorder or the result of a disease process involving the hypothalamus and pituitary gland.
The latest research study released by Market IntelliX evaluates market size and forecasts of Male Hypogonadism Therapy in Global, including the following market information:
Global Male Hypogonadism Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Male Hypogonadism Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Male Hypogonadism Therapy include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Male Hypogonadism Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Male Hypogonadism Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Male Hypogonadism Therapy Market Segment Percentages, by Type, 2021 (%)
Parenteral
Transdermal
Oral
Others
Global Male Hypogonadism Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Male Hypogonadism Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Male Hypogonadism Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Male Hypogonadism Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Male Hypogonadism Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Male Hypogonadism Therapy revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Male Hypogonadism Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Male Hypogonadism Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Male Hypogonadism Therapy Overall Market Size
2.1 Global Male Hypogonadism Therapy Market Size: 2021 VS 2028
2.2 Global Male Hypogonadism Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Male Hypogonadism Therapy Players in Global Market
3.2 Top Global Male Hypogonadism Therapy Companies Ranked by Revenue
3.3 Global Male Hypogonadism Therapy Revenue by Companies
3.4 Top 3 and Top 5 Male Hypogonadism Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Male Hypogonadism Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Male Hypogonadism Therapy Players in Global Market
3.6.1 List of Global Tier 1 Male Hypogonadism Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Male Hypogonadism Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Male Hypogonadism Therapy Market Size Markets, 2021 & 2028
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type - Global Male Hypogonadism Therapy Revenue & Forecasts
4.2.1 By Type - Global Male Hypogonadism Therapy Revenue, 2017-2022
4.2.2 By Type - Global Male Hypogonadism Therapy Revenue, 2023-2028
4.2.3 By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Male Hypogonadism Therapy Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Male Hypogonadism Therapy Revenue & Forecasts
5.2.1 By Application - Global Male Hypogonadism Therapy Revenue, 2017-2022
5.2.2 By Application - Global Male Hypogonadism Therapy Revenue, 2023-2028
5.2.3 By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Male Hypogonadism Therapy Market Size, 2021 & 2028
6.2 By Region - Global Male Hypogonadism Therapy Revenue & Forecasts
6.2.1 By Region - Global Male Hypogonadism Therapy Revenue, 2017-2022
6.2.2 By Region - Global Male Hypogonadism Therapy Revenue, 2023-2028
6.2.3 By Region - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Male Hypogonadism Therapy Revenue, 2017-2028
6.3.2 US Male Hypogonadism Therapy Market Size, 2017-2028
6.3.3 Canada Male Hypogonadism Therapy Market Size, 2017-2028
6.3.4 Mexico Male Hypogonadism Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Male Hypogonadism Therapy Revenue, 2017-2028
6.4.2 Germany Male Hypogonadism Therapy Market Size, 2017-2028
6.4.3 France Male Hypogonadism Therapy Market Size, 2017-2028
6.4.4 U.K. Male Hypogonadism Therapy Market Size, 2017-2028
6.4.5 Italy Male Hypogonadism Therapy Market Size, 2017-2028
6.4.6 Russia Male Hypogonadism Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Male Hypogonadism Therapy Market Size, 2017-2028
6.4.8 Benelux Male Hypogonadism Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Male Hypogonadism Therapy Revenue, 2017-2028
6.5.2 China Male Hypogonadism Therapy Market Size, 2017-2028
6.5.3 Japan Male Hypogonadism Therapy Market Size, 2017-2028
6.5.4 South Korea Male Hypogonadism Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Male Hypogonadism Therapy Market Size, 2017-2028
6.5.6 India Male Hypogonadism Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Male Hypogonadism Therapy Revenue, 2017-2028
6.6.2 Brazil Male Hypogonadism Therapy Market Size, 2017-2028
6.6.3 Argentina Male Hypogonadism Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, 2017-2028
6.7.2 Turkey Male Hypogonadism Therapy Market Size, 2017-2028
6.7.3 Israel Male Hypogonadism Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Male Hypogonadism Therapy Market Size, 2017-2028
6.7.5 UAE Male Hypogonadism Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Male Hypogonadism Therapy Major Product Offerings
7.1.4 Eli Lilly Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Male Hypogonadism Therapy Major Product Offerings
7.2.4 Pfizer Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Male Hypogonadism Therapy Major Product Offerings
7.3.4 AbbVie Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.3.5 AbbVie Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Male Hypogonadism Therapy Major Product Offerings
7.4.4 Novo Nordisk Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Merck KGaA
7.5.1 Merck KGaA Corporate Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Male Hypogonadism Therapy Major Product Offerings
7.5.4 Merck KGaA Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.5.5 Merck KGaA Key News
7.6 Mylan
7.6.1 Mylan Corporate Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Male Hypogonadism Therapy Major Product Offerings
7.6.4 Mylan Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.6.5 Mylan Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Male Hypogonadism Therapy Major Product Offerings
7.7.4 Bayer Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.7.5 Bayer Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva Male Hypogonadism Therapy Major Product Offerings
7.8.4 Teva Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.8.5 Teva Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Male Hypogonadism Therapy Major Product Offerings
7.9.4 Novartis Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Male Hypogonadism Therapy Major Product Offerings
7.10.4 Abbott Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.10.5 Abbott Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Business Overview
7.11.3 Roche Male Hypogonadism Therapy Major Product Offerings
7.11.4 Roche Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.11.5 Roche Key News
7.12 Endo International
7.12.1 Endo International Corporate Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Male Hypogonadism Therapy Major Product Offerings
7.12.4 Endo International Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.12.5 Endo International Key News
7.13 Ipsen
7.13.1 Ipsen Corporate Summary
7.13.2 Ipsen Business Overview
7.13.3 Ipsen Male Hypogonadism Therapy Major Product Offerings
7.13.4 Ipsen Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.13.5 Ipsen Key News
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Corporate Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Male Hypogonadism Therapy Major Product Offerings
7.14.4 ANI Pharmaceuticals Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.14.5 ANI Pharmaceuticals Key News
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Corporate Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Male Hypogonadism Therapy Major Product Offerings
7.15.4 TherapeuticsMD Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
7.15.5 TherapeuticsMD Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Male Hypogonadism Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|